Rosenberg Martin 4
4 · CUBIST PHARMACEUTICALS INC · Filed Jul 3, 2012
Insider Transaction Report
Form 4
Rosenberg Martin
Director
Transactions
- Exercise/Conversion
Common Stock
2012-07-02$22.71/sh+7,500$170,325→ 12,158 total - Exercise/Conversion
Stock Options (Right to Buy)
2012-07-02−7,500→ 10,000 totalExercise: $22.71From: 2007-06-08Exp: 2016-06-08→ Common Stock (7,500 underlying) - Exercise/Conversion
Common Stock
2012-07-02$21.88/sh+2,500$54,700→ 14,658 total - Exercise/Conversion
Stock Options (Right to Buy)
2012-07-02−2,500→ 0 totalExercise: $21.88From: 2008-06-07Exp: 2017-06-07→ Common Stock (2,500 underlying) - Sale
Common Stock
2012-07-02$37.88/sh−10,000$378,756→ 4,658 total
Footnotes (3)
- [F1]Sold pursuant to a Rule 10(b)5-1 Plan
- [F2]This transaction was executed in multiple trades at prices ranging from $37.79 to $37.95. The price reported in the table reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
- [F3]Option vests 100% on one-year anniversary of grant.